Clinical Trials Browser

Breast Neoplasms, Cardiovascular Diseases, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Health Behavior, Endometrial Neoplasms

Clinical Trials

A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases

A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants

Evaluation of an Online Prostate Cancer Screening Decision Aid

PSMA-MRI BX

AH-HA

CURIEFOCALE

Feasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate Cancer

Radium-223 in Combination With Enzalutamide

AASUR in High Risk Prostate Cancer

Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study

Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring

HypProMet

VIOLETTE

PC-PEP

Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy.

Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy

Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer

HOXB13_Mart

Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments

AdOTAC

AccAI

High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy

Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer

PRS-AS

MP-PET-MRI

MK-5684-001

A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients

PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.

CKNO-PRO

Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy

MUSIC-PRT

Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer

MiGHT

Transrectal Tumour Oxygen - US Army

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

Prostate Hypoxia FAZA

Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study

CATALYST

Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer

TOPP

Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment

Turkish Version of the UCLA Prostate Cancer Index

VASA Pro

A Study of Patient Characteristics, Treatment Patterns and Outcomes Among Patients Treated With 177Lu-PSMA-617

ARCH

Bullseye

ARANOTE

Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer

Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)